Pbx 1a Antibodies

Santa Cruz Biotechnology features a diverse variety of Pbx 1a monoclonal antibodies for research focused on understanding Pbx 1a protein function. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Pbx 1a is a member of the pre-B-cell leukemia homeobox (PBX) family of transcription factors, which play a crucial role in regulating gene expression during development and differentiation. Pbx 1a participates in various biological processes, including hematopoiesis and organogenesis, making it essential for normal cellular function and development. Research has shown that abnormal Pbx 1a expression is associated with several types of cancer, highlighting its significance as a potential therapeutic target. Pbx 1a monoclonal antibodies enable detailed investigation of molecular pathways and cellular mechanisms. Understanding Pbx 1a's role in development and disease progression can lead to new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for Pbx 1a support researchers worldwide in advancing scientific knowledge and developing innovative medical treatments.